Kurt W. Tauer, MD, FACP, discusses the expansion of subtyping in breast cancer.
Kurt W. Tauer, MD, FACP
Advertisement
Articles by Kurt W. Tauer, MD, FACP
Kurt W. Tauer, MD, FACP, discusses the potential implications of biosimilars on cancer research funding.
Advertisement
Latest Updated Articles
Dr. Tauer on the Expansion of Subtyping in Breast CancerJanuary 16th 2020
Advertisement
Advertisement
Trending on OncLive
1
ASCO Guideline Update Broadens First-Line Treatment Options for HER2+ Gastroesophageal Cancer
2
CAR T-Cell Therapy Continues to Make Its Case in Early Relapsed Myeloma
3
FDA Awards Fast Track Designation to Safusidenib in IDH1-Mutant Glioma
4
pTVG-HP DNA Vaccine Extends Overall Survival vs Placebo in PSA-Recurrent Prostate Cancer
5